These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8728650)

  • 21. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers.
    Lee Y; Lee YS; Cho SY; Kwon HJ
    Adv Protein Chem Struct Biol; 2015; 99():75-97. PubMed ID: 26067817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of mass spectrometry to structural immunology.
    Downard KM
    J Mass Spectrom; 2000 Apr; 35(4):493-503. PubMed ID: 10797646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes.
    Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R
    Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic peptide vaccines.
    Sesardic D
    J Med Microbiol; 1993 Oct; 39(4):241-2. PubMed ID: 7692052
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical Platforms for Peptide Vaccine Constructs.
    Ramesh S; Cherkupally P; Govender T; Kruger HG; Albericio F; de la Torre BG
    Adv Protein Chem Struct Biol; 2015; 99():99-130. PubMed ID: 26067818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.
    Olive C; Moyle PM; Toth I
    Curr Med Chem; 2007; 14(28):2976-88. PubMed ID: 18220734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of synthetic vaccine candidates against SARS CoV infection.
    Lien SP; Shih YP; Chen HW; Tsai JP; Leng CH; Lin MH; Lin LH; Liu HY; Chou AH; Chang YW; Chen YM; Chong P; Liu SJ
    Biochem Biophys Res Commun; 2007 Jul; 358(3):716-21. PubMed ID: 17506989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of antigenic specificity and design of new vaccines.
    Arnon R; Van Regenmortel MH
    FASEB J; 1992 Nov; 6(14):3265-74. PubMed ID: 1385242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macromolecular self-association of a synthetic peptide derived from the hepatitis B surface antigen: construction of a quaternary epitope.
    Rao KV; Panda SK; Manivel V
    Vaccine; 1992; 10(4):204-8. PubMed ID: 1373260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide mimotopes as candidate vaccines.
    Partidos CD
    Curr Opin Mol Ther; 2000 Feb; 2(1):74-9. PubMed ID: 11249654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
    Tam JP; Lu YA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9084-8. PubMed ID: 2480595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular construction of HIV-gp120 discontinuous epitope mimics by assembly of cyclic peptides on an orthogonal alkyne functionalized TAC-scaffold.
    Werkhoven PR; Elwakiel M; Meuleman TJ; Quarles van Ufford HC; Kruijtzer JAW; Liskamp RMJ
    Org Biomol Chem; 2016 Jan; 14(2):701-710. PubMed ID: 26552661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic vaccines from tumor-associated glycopeptide antigens.
    Westerlind U; Kunz H
    Chimia (Aarau); 2011; 65(1-2):30-4. PubMed ID: 21469441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation of peptide antigens as albumin conjugates for use in detection of serum antibodies by enzyme-linked immunosorbent assay.
    Yu Z; Carter JM; Huang SY; Lackland H; Sigal LH; Stein S
    Bioconjug Chem; 1996; 7(3):338-42. PubMed ID: 8816957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.
    Azmi F; Ahmad Fuaad AA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Bioorg Med Chem; 2014 Nov; 22(22):6401-8. PubMed ID: 25438764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens.
    Reinholdsson-Ljunggren G; Ramqvist T; Ahrlund-Richter L; Dalianis T
    Int J Cancer; 1992 Jan; 50(1):142-6. PubMed ID: 1370225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.
    Cifuentes G; Espejo F; Vargas LE; Parra C; Vanegas M; Patarroyo ME
    Biochemistry; 2004 Jun; 43(21):6545-53. PubMed ID: 15157087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of peptides by antibodies and investigations of affinity using biosensor technology.
    Van Regenmortel MH; Choulier L
    Comb Chem High Throughput Screen; 2001 Aug; 4(5):385-95. PubMed ID: 11472227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.